DelveInsight's Cushing's Disease Market Insights report includes a comprehensive understanding of current treatment practices, Cushing's disease emerging drugs, market share of individual therapies, ...

Lundbeck today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to asedebart (Lu AG13909), Lundbeck's novel investigational anti-ACTH monoclonal ...

Like humans, older dogs can be prone to a variety of health issues. Among the maladies that middle-aged and older dogs experience is Cushing's disease, when the body produces too much of a hormone ...

Please provide your email address to receive an email when new articles are posted on . An updated guideline for the treatment of Cushing’s disease focuses on new therapeutic options and an algorithm ...

A study of more than 250 persons undergoing surgical therapy for Cushing's disease (CD) or nonfunctioning pituitary adenomas (NFPAs) found that patients who achieved remission of CD were more likely ...

Please provide your email address to receive an email when new articles are posted on . Older age was tied to a higher prevalence of 10 comorbidities among a group of 608 people with Cushing’s disease ...

The study covered in this summary was published on Research Square as a preprint and has not yet been peer reviewed. However, the Dex-CRH test also resulted in one (2.5%) false positive case compared ...

Development of autoimmune disease was more common in patients with surgical remission of Cushing's disease than in those with surgically treated nonfunctioning pituitary adenomas (NFPAs), according to ...